Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

More research is needed to understand if GLP-1 agonists affect hair health.

Glycine is a key transmitter in rat spinal cord synapses, often alongside GABA.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Stimulating sensory neurons can increase IGF-I production, which may help treat various diseases and improve tissue health.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

GLP-1 RA medications may be linked to hair loss.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.